Abstract
Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 373-376 |
Number of pages | 4 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 82 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2007 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
Translation of pharmacogenetics into clinically relevant testing modalities. / Baudhuin, L. M.; Langman, L. J.; O'Kane, D. J.
In: Clinical Pharmacology and Therapeutics, Vol. 82, No. 4, 10.2007, p. 373-376.Research output: Contribution to journal › Short survey
}
TY - JOUR
T1 - Translation of pharmacogenetics into clinically relevant testing modalities
AU - Baudhuin, L. M.
AU - Langman, L. J.
AU - O'Kane, D. J.
PY - 2007/10
Y1 - 2007/10
N2 - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.
AB - Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.
UR - http://www.scopus.com/inward/record.url?scp=34548668192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548668192&partnerID=8YFLogxK
U2 - 10.1038/sj.clpt.6100350
DO - 10.1038/sj.clpt.6100350
M3 - Short survey
C2 - 17851577
AN - SCOPUS:34548668192
VL - 82
SP - 373
EP - 376
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 4
ER -